Rollie Carlson Discusses Host Response Testing Gains Attention in Sepsis Diagnosis and Antibiotic Stewardship
Excerpt from a discussion with Tero Vesalainen from CLPMag.
A recent poll highlights growing interest in host response testing for sepsis. Immunexpress CEO Rollie Carlson discusses the findings and the future of rapid diagnostics.
In a recent poll conducted by Immunexpress following a Sepsis Alliance webinar, 73% of healthcare professionals and patient advocates said they believe host response testing can help guide antibiotic stewardship efforts.
The results also revealed a concern among respondents that many patients suspected of sepsis are being overdiagnosed and overtreated.
Rollie Carlson, PhD, CEO of Immunexpress, offers a perspective on what the poll results reveal about clinician attitudes, how technologies like SeptiCyte RAPID aim to support faster and more accurate diagnosis, and why improving sepsis detection remains a critical component of combating antimicrobial resistance.
Carlson also discusses where sepsis testing is headed, including the role of personalized approaches and next-generation diagnostics.
Read the rest of the discussion at CLPMag.com.